Literature DB >> 3499437

Important differences in cationic amino acid transport by lysosomal system c and system y+ of the human fibroblast.

R L Pisoni1, J G Thoene, R M Lemons, H N Christensen.   

Abstract

Superficial similarities led us to extend our designation for the transport of the plasma membrane for cationic amino acids, y+, to the lysosomal system also serving for such amino acids. Further study on the purified lysosomes of human skin fibroblasts leads us now to redesignate the lysosomal system as c (for cationic), rather than y+, to emphasize important contrasts. Lysosomal uptake of arginine at pH 7.0 was linear during the first 2 min, but attained a steady state in 6 min. This arginine uptake was Na+-independent and was tripled in rate when the lysosomes had first been loaded with the cationic amino acid analog, S-2-aminoethyl-L-cysteine. Uptake was slowed to one-third when 2 mM MgATP was added to the incubation mixture. The following differences in cationic amino acid influx between lysosomal System c and the plasma membrane System y+ became apparent: 1) arginine influx is increased 10-fold by raising the external pH from 5.0 to 7.0. This effect favors net entry of cationic amino acids under the H+ gradient prevailing in vivo. In contrast, arginine uptake across the plasma membrane is insensitive to pH changes in this range. 2) The Km of arginine uptake by lysosomal System c, 0.32 mM, is eight times that for System y+ arginine uptake by the fibroblast. 3) Certain neutral amino acids in the presence of Na+ are accepted as surrogate substrates by System y+, but not by lysosomal system c. 4) Cationic amino acids in which the alpha-amino group is monomethylated or the distal amino group is quaternary, also D-arginine, are recognized by lysosomal System c, whereas System y+ has little affinity for these analogs. This broader substrate specificity of lysosomal system c led us to discover that thiocholine serves to deplete accumulated cystine from cystinotic fibroblasts as effectively as does the therapeutic agent, cysteamine. The quaternary nitrogen of thiocholine renders the mixed disulfide formed when it reacts with cystine unsatisfactory as a substrate for System y+.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499437

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Molecular physiology and pathophysiology of lysosomal membrane transporters.

Authors:  C Sagné; B Gasnier
Journal:  J Inherit Metab Dis       Date:  2008-04-15       Impact factor: 4.982

2.  ATP stimulates lysosomal sulphate transport at neutral pH: evidence for phosphorylation of the lysosomal sulphate carrier.

Authors:  H F Chou; M Passage; A J Jonas
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Has the basic metabolic defect of cystinosis been discovered?

Authors:  J A Schneider
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

4.  Demonstration of adenosine deaminase activity in human fibroblast lysosomes.

Authors:  E R Lindley; R L Pisoni
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy.

Authors:  Adrien Jézégou; Elisa Llinares; Christine Anne; Sylvie Kieffer-Jaquinod; Seana O'Regan; Joëlle Aupetit; Allel Chabli; Corinne Sagné; Cécile Debacker; Bernadette Chadefaux-Vekemans; Agnès Journet; Bruno André; Bruno Gasnier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-20       Impact factor: 11.205

6.  Biochemical and genetic analysis of ANK in arthritis and bone disease.

Authors:  Kyle A Gurley; Richard J Reimer; David M Kingsley
Journal:  Am J Hum Genet       Date:  2006-10-16       Impact factor: 11.025

Review 7.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

8.  N-acetyl-D-glucosamine countertransport in lysosomal membrane vesicles.

Authors:  A J Jonas; H Jobe
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

9.  A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.

Authors:  Yoojin Kim; Denia Ramirez-Montealegre; David A Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

10.  Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes.

Authors:  Monther Abu-Remaileh; Gregory A Wyant; Choah Kim; Nouf N Laqtom; Maria Abbasi; Sze Ham Chan; Elizaveta Freinkman; David M Sabatini
Journal:  Science       Date:  2017-10-26       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.